Touyun Biotech Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-88.00
-272.00
-199.00
-122.00
-147.00
-255.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
17.00
15.00
-36.00
-38.00
-11.00
-63.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-2.00
-17.00
-43.00
-69.00
-62.00
-80.00
Cash Flow from Investing Activities
16.00
-64.00
-10.00
-47.00
-32.00
155.00
Cash Flow from Financing Activities
15.00
-32.00
95.00
23.00
145.00
-7.00
Net Cash Inflow / Outflow
30.00
-112.00
50.00
-97.00
55.00
67.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
1.00
8.00
-3.00
4.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Touyun Biotech Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-88.366
-20.7043384964638
-68.00
-326.80%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
17.374
-95.3379709190961
112.00
118.22%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-2.616
13.8509595879939
-15.00
-118.89%
Cash Flow from Investing Activities
16.768
-71.5956372159349
87.00
123.42%
Cash Flow from Financing Activities
15.743
7.94952921324219
8.00
98.04%
Net Cash Inflow / Outflow
30.505
-49.7658743709515
79.00
161.30%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.61
0.0292740437476185
0.00
1983.76%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 84.67% vs 61.19% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-2.62
-17.07
84.67%






